Literature DB >> 10613934

Response to repeated equal doses of epinephrine during cardiopulmonary resuscitation in dogs.

G Bar-Joseph1, T Weinberger, S Ben-Haim.   

Abstract

STUDY
OBJECTIVE: Advanced cardiac life support (ACLS) guidelines recommend a 3- to 5-minute interval between repeated doses of epinephrine. This recommendation does not take into account the dose of epinephrine used, and only very limited data exist regarding the hemodynamic responses to repeated "high" doses of epinephrine. The objective of this study was to analyze the hemodynamic responses to repeated, equal, high doses of epinephrine administered during cardiopulmonary resuscitation (CPR) in a canine model of ventricular fibrillation (VF).
METHODS: This study used a secondary analysis of data collected in a prospective, randomized study, primarily designed to assess the effects of acid buffers in a canine model of cardiac arrest. VF was electrically induced. After 10 minutes, CPR was initiated, including ventilation with FIO(2)=1.0, external chest compressions, administration of epinephrine (0.1 mg/kg repeated every 5 minutes) and defibrillation. Animals were randomized to receive either NaHCO(3), Carbicarb, tromethamine (THAM), or NaCl. The hemodynamic variables were sampled from each experiment's paper chart at 1-minute intervals, and the responses to the first 4 doses of epinephrine were compared.
RESULTS: Thirty-six animals (9 in each buffer group) were included in this analysis. Systolic, diastolic, and coronary perfusion pressures increased steeply (by 100%, 130%, and 190%, respectively) only after the first epinephrine dose. These pressures peaked at 2 to 3 minutes and decreased only slightly and insignificantly during the rest of the 5-minute interval, until the next epinephrine dose. No further significant increases in arterial pressures were observed in response to the next 3 doses of epinephrine, administered 5 minutes apart.
CONCLUSION: The hemodynamic effects of high-dose epinephrine (0.1 mg/kg) during CPR appear to last longer than 5 minutes. Therefore, longer intervals between doses may be justified with high doses of epinephrine.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10613934     DOI: 10.1016/s0196-0644(00)70098-9

Source DB:  PubMed          Journal:  Ann Emerg Med        ISSN: 0196-0644            Impact factor:   5.721


  5 in total

Review 1.  Drug administration in animal studies of cardiac arrest does not reflect human clinical experience.

Authors:  Joshua C Reynolds; Jon C Rittenberger; James J Menegazzi
Journal:  Resuscitation       Date:  2007-03-13       Impact factor: 5.262

2.  Repeated epinephrine doses during prolonged cardiopulmonary resuscitation have limited effects on myocardial blood flow: a randomized porcine study.

Authors:  Henrik Wagner; Michael Götberg; Bjarne Madsen Hardig; Malin Rundgren; Jonas Carlson; Matthias Götberg; David Zughaft; David Erlinge; Göran K Olivecrona
Journal:  BMC Cardiovasc Disord       Date:  2014-12-20       Impact factor: 2.298

3.  Impact of epinephrine administration frequency in out-of-hospital cardiac arrest patients: a retrospective analysis in a tertiary hospital setting.

Authors:  Mohammed A Al-Mulhim; Mohammed S Alshahrani; Laila Perlas Asonto; Ahmad Abdulhady; Talal M Almutairi; Mariam Hajji; Mohammed A Alrubaish; Khalid N Almulhim; Mariam H Al-Sulaiman; Layla B Al-Qahtani
Journal:  J Int Med Res       Date:  2019-07-16       Impact factor: 1.671

4.  Intraosseous versus intravenous vascular access during cardiopulmonary resuscitation for out-of-hospital cardiac arrest: a systematic review and meta-analysis of observational studies.

Authors:  Yu-Lin Hsieh; Meng-Che Wu; Eric H Chou; Chih-Hung Wang; Jon Wolfshohl; James d'Etienne; Chien-Hua Huang; Tsung-Chien Lu; Edward Pei-Chuan Huang; Wen-Jone Chen
Journal:  Scand J Trauma Resusc Emerg Med       Date:  2021-03-08       Impact factor: 2.953

5.  Epinephrine's effects on cerebrovascular and systemic hemodynamics during cardiopulmonary resuscitation.

Authors:  Constantine D Mavroudis; Tiffany S Ko; Ryan W Morgan; Lindsay E Volk; William P Landis; Benjamin Smood; Rui Xiao; Marco Hefti; Timothy W Boorady; Alexandra Marquez; Michael Karlsson; Daniel J Licht; Vinay M Nadkarni; Robert A Berg; Robert M Sutton; Todd J Kilbaugh
Journal:  Crit Care       Date:  2020-09-29       Impact factor: 9.097

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.